BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21968896)

  • 1. [Epithelial ovarian cancer - a change of paradigm].
    Heinzelmann-Schwarz V
    Ther Umsch; 2011 Oct; 68(10):565-72. PubMed ID: 21968896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy fails to improve survival in advanced ovarian cancer: but is it the real culprit?
    Di Giorgio A; Sammartino P; Biacchi D
    Int J Gynecol Cancer; 2011 May; 21(4):596. PubMed ID: 21543925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor size and prognosis for patients with epithelial ovarian carcinoma at early stage].
    Lazarov N; Lazarov L; Lazarov S
    Akush Ginekol (Sofiia); 2013; 52(4):10-2. PubMed ID: 24283071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival of epithelial ovarian cancer.
    Linasmita V; Pattaraarchachai J; Daengdeelert P
    Int J Gynaecol Obstet; 2004 Apr; 85(1):66-9. PubMed ID: 15050477
    [No Abstract]   [Full Text] [Related]  

  • 5. Frontline treatment of epithelial ovarian cancer.
    Goh J; Mohan GR; Ladwa R; Ananda S; Cohen PA; Baron-Hay S
    Asia Pac J Clin Oncol; 2015 Dec; 11 Suppl 6():1-16. PubMed ID: 26669253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial ovarian cancer.
    Ng JS; Low JJ; Ilancheran A
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):337-45. PubMed ID: 22281513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.
    van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA
    Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.
    Zhu J; Wang H; Liu CC; Lu Y; Tang H
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2339-45. PubMed ID: 27566683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epithelial ovarian cancer].
    Hilpert F; Krause G; Venhoff L; Kühnle E; Schem C; Maass N
    Ther Umsch; 2007 Jul; 64(7):375-80. PubMed ID: 17948754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
    Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
    Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of early ovarian cancer.
    Sonoda Y
    Oncology (Williston Park); 2004 Mar; 18(3):343-56; discussion 358, 361-2. PubMed ID: 15065703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
    Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in epithelial ovarian cancer: A population-based study.
    Chang LC; Huang CF; Lai MS; Shen LJ; Wu FL; Cheng WF
    PLoS One; 2018; 13(3):e0194993. PubMed ID: 29579127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
    Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
    Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery.
    Son JH; Lee JH; Jung JA; Kong TW; Paek J; Chang SJ; Ryu HS
    Gynecol Oncol; 2018 Oct; 151(1):32-38. PubMed ID: 30122310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Hall TR; Dizon DS
    Clin Adv Hematol Oncol; 2016 Apr; 14(4):262-8. PubMed ID: 27166608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of outcomes of secondary debulking surgery for recurrent epithelial ovarian cancer with favorable prognostic factors.
    Nasu K; Kai K; Hirakawa T; Nishida M; Matsumoto H; Kawano Y; Narahara H
    J Obstet Gynaecol Res; 2014 Mar; 40(3):791-6. PubMed ID: 24245582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
    Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary ovarian cancer.
    Chow SN; Chen YP
    Int Surg; 1987; 72(3):154-9. PubMed ID: 2824396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.